Lyell Immunopharma, Inc. - 10-Q Filing
Lyell Immunopharma reports Q3 2026 financial position including updates on ICT license acquisition and collaborative arrangements.
Tickers: $LYEL
Read the full article at SEC EDGAR
Part of the story Lyell Immunopharma, Inc. - 10-Q Filing (3 articles)